Diamond Biofund (TPE:6901) Debt-to-Asset : 0.01 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:6901 Diamond Biofund Inc TPE:6901
24 GF Score
Price NT$15.45
! 2 Warning Signs
View Full Analysis

What is Diamond Biofund Debt-to-Asset?

Diamond Biofund TPE:6901 -0.32% 24 Debt-to-Asset is 0.01 as of Jun. 2026. GuruFocus rates TPE:6901 with a GF Score™ of 24/100. The stock has 2 warning signs investors should review.

Diamond Biofund's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was NT$25.18 Mil. Diamond Biofund's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was NT$56.53 Mil. Diamond Biofund's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Jun. 2026 was NT$12,436.23 Mil. Diamond Biofund's debt to asset for the quarter that ended in Jun. 2026 was 0.01.

Diamond Biofund  (TPE:6901) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Diamond Biofund Debt-to-Asset Related Terms

Diamond Biofund Debt-to-Asset Historical Data

* Premium members only.

The historical data trend for Diamond Biofund's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Diamond Biofund Debt-to-Asset Chart

Diamond Biofund Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Debt-to-Asset
Get a 7-Day Free Trial 0.00 0.00 0.01 0.01 0.01

Diamond Biofund Quarterly Data
Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.01 0.01 0.01 0.01

TPE:6901 vs BLK, BX, KKR: Debt-to-Asset Comparison

For the Asset Management subindustry, Diamond Biofund's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Diamond Biofund Debt-to-Asset vs Asset Management Industry

For the Asset Management industry and Financial Services sector, Diamond Biofund's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Diamond Biofund's Debt-to-Asset falls into.


TPE:6901
24GF Score
Diamond Biofund Inc TPE:6901
Debt-to-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Diamond Biofund Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Diamond Biofund's Debt-to-Asset for the fiscal year that ended in Dec. 2025 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(24.812 + 69.122) / 9358.663
=0.01

Diamond Biofund's Debt-to-Asset for the quarter that ended in Jun. 2026 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(25.182 + 56.533) / 12436.225
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Debt-to-Asset →
What does a Debt-to-Asset of 0.01 mean?
Diamond Biofund (TPE:6901) has a Debt-to-Asset of 0.01 as of Jun. 2026. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on Diamond Biofund and its competitors.
Is Diamond Biofund's Debt-to-Asset too high?
Diamond Biofund's current Debt-to-Asset is 0.01. Overall, Diamond Biofund has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Diamond Biofund's Debt-to-Asset compare to BLK and BX?
Diamond Biofund's Debt-to-Asset of 0.01 can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Asset for an Asset Management company?
A good Debt-to-Asset depends on the Asset Management industry context. However, Debt-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Asset mean?
A high Debt-to-Asset can signal that a stock is expensive relative to its fundamentals. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on Diamond Biofund and its competitors. Diamond Biofund's current Debt-to-Asset is 0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diamond Biofund stock overvalued right now?
Diamond Biofund (TPE:6901) has a current Debt-to-Asset of 0.01. The current Debt-to-Asset is 0.01. Diamond Biofund's overall GF Score™ is 24/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Asset calculated?
Debt-to-Asset is calculated from a company's financial statements. For Diamond Biofund (TPE:6901), the current Debt-to-Asset is 0.01 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Diamond Biofund Business Description

Address Zhongxiao West Road, 34th Floor, No. 66, Section 1, Zhongzheng District, Taipei, TWN, 100
Diamond Biofund Inc is a sustainable biotech venture capital that focuses on the field of biotechnology and medical investment, targeting competitive investment targets, including new drug research and development, high-end medical equipment, medical service technology, medical access, agricultural biotechnology.
24GF Score

Get the complete analysis for TPE:6901

Debt-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$15.45
Price